98 related articles for article (PubMed ID: 9864435)
1. Relationships betxween Fas expression, activation molecule CD25, and functional activity of tumor-associated lymphomonocytes from neoplastic effusions.
Mantovani G; Macciò A; Massa E; Lai P; Manca G; Mudu C; Versace R; Pusceddu G
Oncol Rep; 1999; 6(1):235-9. PubMed ID: 9864435
[TBL] [Abstract][Full Text] [Related]
2. Tumor-associated lymphocytes (TAL) are competent to produce higher levels of cytokines in neoplastic pleural and peritoneal effusions than those found in sera and are able to release into culture higher levels of IL-2 and IL-6 than those released by PBMC.
Mantovani G; Macciò A; Versace R; Pisano M; Lai P; Esu S; Ghiani M; Dessì D; Turnu E; Santona MC
J Mol Med (Berl); 1995 Aug; 73(8):409-16. PubMed ID: 8528743
[TBL] [Abstract][Full Text] [Related]
3. Restoration of functional defects in peripheral blood mononuclear cells isolated from cancer patients by thiol antioxidants alpha-lipoic acid and N-acetyl cysteine.
Mantovani G; Macciò A; Melis G; Mura L; Massa E; Mudu MC
Int J Cancer; 2000 Jun; 86(6):842-7. PubMed ID: 10842199
[TBL] [Abstract][Full Text] [Related]
4. Preovulatory human follicular fluid in vitro inhibits interleukin (IL)-1 alpha, IL-2, and production and expression of p55 chain IL-2 receptor of lymphomonocytes.
Macciò A; Mantovani G; Turnu E; Artini P; Contu G; Volpe A
Fertil Steril; 1994 Aug; 62(2):327-32. PubMed ID: 8034080
[TBL] [Abstract][Full Text] [Related]
5. Expression of Fas and Fas ligand and apoptosis in tumor-associated lymphocytes and in tumor cells from malignant pleural effusions.
Sikora J; Dworacki G; Zeromski J
Nat Immun; 1998; 16(5-6):244-55. PubMed ID: 11061592
[TBL] [Abstract][Full Text] [Related]
6. Regulation of bcl-2 and fas expression in primary activation of human peripheral lymphocytes is not sensitive to dexamethasone or cyclosporin-A.
Sfikakis PP; Souliotis VL; Akbar AN; Katsilambros N; Hoffbrand VA; Panayiotidis P
Hum Immunol; 1996 Oct; 50(2):121-6. PubMed ID: 8891735
[TBL] [Abstract][Full Text] [Related]
7. Role of cytokines in promoting immune escape of FasL-expressing human colon cancer cells.
Xu T; Sun BC; Li Q; Hao XS
World J Gastroenterol; 2005 Jul; 11(25):3915-9. PubMed ID: 15991293
[TBL] [Abstract][Full Text] [Related]
8. Enhanced apoptosis of peripheral blood mononuclear cells in cardiac transplanted patients undergoing chronic immunosuppressive treatment.
Di Renzo M; Capecchi PL; Camurri A; Di Ciolla F; Maccherini M; Lisi G; Pompella G; Pasqui AL; Auteri A; Abbracchio MP; Pasini FL
Transpl Immunol; 2002 Nov; 10(4):269-75. PubMed ID: 12507398
[TBL] [Abstract][Full Text] [Related]
9. On the role and significance of Fas (Apo-1/CD95) ligand (FasL) expression in immune privileged tissues and cancer cells using multiple myeloma as a model.
Greil R; Egle A; Villunger A
Leuk Lymphoma; 1998 Nov; 31(5-6):477-90. PubMed ID: 9922038
[TBL] [Abstract][Full Text] [Related]
10. Tumor-associated lympho-monocytes from neoplastic effusions are immunologically defective in comparison with patient autologous PBMCs but are capable of releasing high amounts of various cytokines.
Mantovani G; Macciò A; Pisano M; Versace R; Lai P; Esu S; Massa E; Ghiani M; Dessì D; Melis GB; Del Giacco GS
Int J Cancer; 1997 May; 71(5):724-31. PubMed ID: 9180137
[TBL] [Abstract][Full Text] [Related]
11. Oxytocin both increases proliferative response of peripheral blood lymphomonocytes to phytohemagglutinin and reverses immunosuppressive estrogen activity.
Macciò A; Madeddu C; Chessa P; Panzone F; Lissoni P; Mantovani G
In Vivo; 2010; 24(2):157-63. PubMed ID: 20363988
[TBL] [Abstract][Full Text] [Related]
12. Altered gene transcription after burn injury results in depressed T-lymphocyte activation.
Horgan AF; Mendez MV; O'Riordain DS; Holzheimer RG; Mannick JA; Rodrick ML
Ann Surg; 1994 Sep; 220(3):342-51; discussion 351-2. PubMed ID: 8092900
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic and functional analysis of peripheral blood mononuclear cells in generalised aggressive and chronic periodontitis patients.
Emingil G; Karaarslan F; Keskinoğlu A; Coker I; Atilla G
J Int Acad Periodontol; 2001 Oct; 3(4):87-94. PubMed ID: 12666947
[TBL] [Abstract][Full Text] [Related]
14. Role of interleukin-2 (IL-2) in cancer-related immune deficiency: in vitro response to IL-2, production of IL-2, and IL-2 receptor expression in patients with advanced cancer.
Mantovani G; Coiana A; Massidda A; Proto E; Floris C; Macciò A; Pusceddu G; Del Giacco GS
Cancer Detect Prev; 1988; 12(1-6):149-59. PubMed ID: 3263194
[TBL] [Abstract][Full Text] [Related]
15. Artesunate and a major metabolite, dihydroartemisinin, diminish mitogen-induced lymphocyte proliferation and activation.
Veerasubramanian P; Gosi P; Limsomwong C; Walsh DS
Southeast Asian J Trop Med Public Health; 2006 Sep; 37(5):838-47. PubMed ID: 17333724
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of interleukin-2 receptor gene activation and protein expression by dideoxynucleoside analogs.
Viora M; Camponeschi B
Cell Immunol; 1995 Jul; 163(2):289-95. PubMed ID: 7606800
[TBL] [Abstract][Full Text] [Related]
17. Proliferation, interleukin-2 production and receptor expression in peripheral blood mononuclear cells from colorectal cancer patients.
Chang KJ; Wang SM; Lee CS; Hsieh KH; Chen KM
J Formos Med Assoc; 1990 Mar; 89(3):205-13. PubMed ID: 1974593
[TBL] [Abstract][Full Text] [Related]
18. Expression of receptors for IgA on mitogen-stimulated human T lymphocytes.
Millet I; Panaye G; Revillard JP
Eur J Immunol; 1988 Apr; 18(4):621-6. PubMed ID: 3259188
[TBL] [Abstract][Full Text] [Related]
19. Sequential expression of protooncogenes during lectin-stimulated mitogenesis of normal human lymphocytes.
Reed JC; Alpers JD; Nowell PC; Hoover RG
Proc Natl Acad Sci U S A; 1986 Jun; 83(11):3982-6. PubMed ID: 3012540
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-4 receptors on human blood mononuclear cells.
Zuber CE; Galizzi JP; Harada N; Durand I; Banchereau J
Cell Immunol; 1990 Sep; 129(2):329-40. PubMed ID: 2383894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
